LYON, France — The drug zodasiran (formerly ARO-ANG3), which targets the production of a liver protein, substantially lowers triglyceride and a range of lipoprotein levels in...
SAN DIEGO, California — Researchers are unraveling the complex relationship between cardiovascular (CV)- and stroke-related outcomes in migraine with, and without, aura. Early results of one...
HOUSTON — Narcolepsy is associated with a significantly increased risk for cardiovascular disease (CVD) and major adverse cardiac events (MACEs), independent of common comorbid conditions and...
BASEL, SWITZERLAND — The anti-inflammatory agent colchicine failed to show significant benefit in the treatment of patients with non-cardioembolic ischemic stroke in the primary analysis of...